Trabeculectomy Versus Tube Outcome in Neovascular Glaucoma Oral Presentation - Observational Study - Resident

Daisy Syakhsiatusy Syahiqoh (1) , Fifin Luthfia Rahmi (2) , Denti Puspasari (3) , Maharani (4)
(1) , Indonesia
(2) , Indonesia
(3) , Indonesia
(4) , Indonesia

Abstract

Introduction & Objectives
Neovascular glaucoma (NVG) is known to be a refractory form of glaucoma, which frequently
requires the integrated use of medical, laser and incisional surgery. Tube-shunt implantation and
trabeculectomy with antifibrotic agent are the two most-popular incisional procedures for managing
refractory glaucoma. This study aims to compare surgical outcome between patients who underwent
trabeculectomy versus tube-shunt implantation for the treatment of NVG.



Methods
A retrospective study was held of NVG patients that underwent trabeculectomy and tube-shunt
implantation between January 2020 - December 2022 at Dr. Kariadi Hospital, Semarang. IOP
outcome and success rate was measured at 3 months post operatively. Statistical analysis was used
to compare the outcome between groups, p<0.05 was considered significant.



Results
There were no significant differences in characteristics between groups at baseline. Mean IOP
measured at 3 months post operatively was 18.58 ± 5.53 and 15.94 ± 10.79 in trabeculectomy and
tube group respectively (p=0.04), complete success rate was 18.8% in trabeculectomy and 25% in
tube group, qualified success rate was 37.5% in trabeculectomy and 56.3% in tube group. Greater
failure rate was observed in trabeculectomy group (43.8%).



Conclusion
Compared to trabeculectomy, tube-shunt implantation has lower IOP at 3 months post operatively in
NVG. Greater failure rate was observed in trabeculectomy.

Full text article

Generated from XML file

References

Urbonaviciute D, Buteikiene D, Januleviciene I. A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment. Medicina 2022;58(1870):1-14.

Senthil S, Dada T, Das T, et al. Neovascular glaucoma - A review. Indian Journal of Ophthalmology 2021;69(3):525-534.

Senthil S, Chary R, Ali MH, et al. Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure. Indian Journal of Ophthalmology 2021;69(11):3341-3348.

Tokumo K, Komatsu K, Yuasa Y, et al. Treatment outcomes in the neovascular glaucoma tube versus trabeculectomy study. Graefe's Archive for Clinical and Experimental Ophthalmology 2021;259(10):3067-3076.

Shen CC, Salim S, Du H, Netland PA. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clinical Ophthalmology 2011;5:281–286.

Liu L, Xu Y, Huang Z, Wang X. Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications. BMC Ophthalmology 2016;16(1):65.

Im Y-W, Lym H-S, Park C-K, Moon J-I. Comparison of Mitomycin C Trabeculectomy and Ahmed Valve Implant Surgery for Neovascular Glaucoma. J Korean Ophthalmol Soc 2004;45(9):1515-1521.

Hyung SM, Kim SK. Midd-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol 2001;15(2):98-106.

Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with Mitomycin C for Neovascular Glaucoma: Prognostic Factors for Surgical Failure. American Journal of Ophthalmology 2009;147(5):912-918.e1.

Higashide T, Ohkubo S, Sugiyama K. Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma. PLOS ONE 2015;10(8):e0135766.

Al Obeidan S, Osman E, Al-Amro S, Kangave D, Abu ElAsrar A. Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma. Eur J Ophthalmol 2008;18(5):758-764.

Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Ito S. Trabeculectomy with Mitomycin C for Treatment of Neovascular Glaucoma in Diabetic Patients. Ophthalmologica 2006;220(6):383-388.

Mandal A, Majji A, Mandal S, et al. Mitomycin-Caugmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol 2002;50:287-93.

Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 2007;21(1):65-70.

Iwasaki K, Kojima S, Wajima R, et al. Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study. Ophthalmology Glaucoma 2022;5(6):672-680.

Authors

Daisy Syakhsiatusy Syahiqoh
Fifin Luthfia Rahmi
Denti Puspasari
Maharani
Syahiqoh, D. S. ., Rahmi, F. L. ., Puspasari, D. ., & Maharani. (2024). Trabeculectomy Versus Tube Outcome in Neovascular Glaucoma: Oral Presentation - Observational Study - Resident. Ophthalmologica Indonesiana, 49(S2). https://doi.org/10.35749/73qxtp82

Article Details

How to Cite

Syahiqoh, D. S. ., Rahmi, F. L. ., Puspasari, D. ., & Maharani. (2024). Trabeculectomy Versus Tube Outcome in Neovascular Glaucoma: Oral Presentation - Observational Study - Resident. Ophthalmologica Indonesiana, 49(S2). https://doi.org/10.35749/73qxtp82

Management of Uveitic Glaucoma in Children with Blau Syndrome

Ivone Caroline, Elsa Gustianty, Andika Prahasta, R. Maula Rifada
Abstract View : 132
Download :172